The Strategy of Implementation of the ERAS Protocol After Esophageal Surgery

Not Applicable

Recruiting

• Conditions: Esophageal Diseases; ERAS
• Interventions: Procedure: esophagectomy with simultaneous reconstruction

• Registration Number: NCT05311787
• Lead Sponsor: Vishnevsky Center of Surgery

Brief Summary

Application of the perioperative enhanced recovery protocol has allowed to carry out esophagectomy to the patients with severe comorbidities and has led reducing the risks of severe postoperative complications.

Detailed Description

The clinical trial included the parients who participated in the protocol ERAS since 2011, who uderwent esophagectomy with simultaneous reconstruction. The parients had benign or malignant esophageal diseases. The ERAS protocol consisted of components of perioperative recovery. The number of patients until now has reached 400 patients. During trial there was modifications of aspects of ERAS protocol such as a rejection of nasogastric tube or cervical drenage. The role of multidisplinary team is the main success of the result of the implemented ERAS protocol.

Study Timeline

• Study Start: 2011-01
• Primary Completion: 2022-03
• Study First Submitted: 2022-03-22
• Status Verified: 2022-04
• Study First Submitted QC: 2022-04-02
• Last Update Submitted: 2022-04-02
• Study First Posted: 2022-04-05
• Last Update Posted: 2022-04-05
• Study Completion: 2026-03

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• all patients with esophageal diseases

Exclusion Criteria

• before 18 years old
• who do not need surgery as a treatment
• who not underwent simultaneous recontruction

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Early oral feeding	esophagectomy with simultaneous reconstruction	The part of our investigation was prostective randomised trial which compared the result of patients with early oral feeding (since first day) and traditional group (oral feeding since 5th day)

Primary Outcome Measures

Name	Time	Method
morbidity	30 days	the rate of morbidity after surgery
mortality	30 days	the rate of mortality after surgery

Trial Locations

Locations (1)

Mary Yan; 🇷🇺 Moscow, Russian Federation